All Curated Mutation Sites in EBV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

EBNA-3B/EBNA-3C

Keyword: Nasopharyngeal Carcinoma-9466647

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	9466647	C102332A	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
2	9466647	G102637A	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
3	9466647	T102612C	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
4	9466647	G102407T	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
5	9466647	G102594T	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
6	9466647	102607_102636del	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
7	9466647	T102621G	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
8	9466647	T102975G	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
9	9466647	C102994G	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
10	9466647	L61I	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
11	9466647	E54D	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
12	9466647	A206S	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
13	9466647	T102609A	BZLF1	BZLF1	Nasopharyngeal Carcinoma	L	View
14	9466647	69_bp del	LMP-1	LMP-1	Nasopharyngeal Carcinoma	L	View
15	9466647	346_355del	LMP-1	LMP-1	Nasopharyngeal Carcinoma	L	View
16	9466647	T168266C	LMP-1	LMP-1	Nasopharyngeal Carcinoma	L	View

Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.